Patents by Inventor Dazhan Liu

Dazhan Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tenofovir alafenamide hemifumarate
    Patent number: 9296769
    Abstract: A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: March 29, 2016
    Assignee: Gilead Sciences, Inc.
    Inventors: Dazhan Liu, Bing Shi, Fang Wang, Richard Hung Chiu Yu
  • TENOFOVIR ALAFENAMIDE HEMIFUMARATE
    Publication number: 20140187773
    Abstract: A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
    Type: Application
    Filed: March 5, 2014
    Publication date: July 3, 2014
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Dazhan Liu, Bing Shi, Fang Wang, Richard Hung Chiu Yu
  • Tenofovir alafenamide hemifumarate
    Patent number: 8754065
    Abstract: A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: June 17, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: Dazhan Liu, Bing Shi, Fang Wang, Richard Hung Chiu Yu
  • Tenofovir alafenamide hemifumarate
    Patent number: 8697675
    Abstract: A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: April 15, 2014
    Assignee: Gilead Sciences, Inc.
    Inventors: Dazhan Liu, Bing Shi, Fang Wang, Richard Hung Chiu Yu
  • TENOFOVIR ALAFENAMIDE HEMIFUMARATE
    Publication number: 20130065856
    Abstract: A hemifumarate form of 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine (tenofovir alafenamide), and antiviral therapy using tenofovir alafenamide hemifumarate (e.g., anti-HIV and anti-HBV therapies).
    Type: Application
    Filed: August 15, 2012
    Publication date: March 14, 2013
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Dazhan Liu, Bing Shi, Fang Wang, Richard Hung Chiu Yu